Intrinsic value of Universal Health Services Cl B - UHS

Previous Close

$118.84

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$118.84

 
Intrinsic value

$135.37

 
Up/down potential

+14%

 
Rating

hold

 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of UHS stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 11.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  8.00
  7.00
  6.80
  6.62
  6.46
  6.31
  6.18
  6.06
  5.96
  5.86
  5.77
  5.70
  5.63
  5.56
  5.51
  5.46
  5.41
  5.37
  5.33
  5.30
  5.27
  5.24
  5.22
  5.20
  5.18
  5.16
  5.14
  5.13
  5.12
  5.10
  5.09
Revenue, $m
  9,766
  10,450
  11,160
  11,899
  12,667
  13,467
  14,299
  15,166
  16,070
  17,012
  17,994
  19,019
  20,090
  21,207
  22,376
  23,597
  24,874
  26,210
  27,608
  29,071
  30,603
  32,208
  33,888
  35,650
  37,495
  39,430
  41,458
  43,584
  45,814
  48,153
  50,606
Variable operating expenses, $m
 
  8,971
  9,555
  10,162
  10,794
  11,452
  12,136
  12,849
  13,592
  14,366
  15,174
  15,639
  16,519
  17,438
  18,398
  19,403
  20,453
  21,551
  22,700
  23,904
  25,163
  26,483
  27,865
  29,313
  30,831
  32,421
  34,089
  35,837
  37,671
  39,594
  41,611
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  8,485
  8,971
  9,555
  10,162
  10,794
  11,452
  12,136
  12,849
  13,592
  14,366
  15,174
  15,639
  16,519
  17,438
  18,398
  19,403
  20,453
  21,551
  22,700
  23,904
  25,163
  26,483
  27,865
  29,313
  30,831
  32,421
  34,089
  35,837
  37,671
  39,594
  41,611
Operating income, $m
  1,281
  1,479
  1,605
  1,737
  1,873
  2,015
  2,163
  2,317
  2,478
  2,645
  2,820
  3,381
  3,571
  3,770
  3,977
  4,194
  4,421
  4,659
  4,907
  5,167
  5,440
  5,725
  6,024
  6,337
  6,665
  7,009
  7,369
  7,747
  8,143
  8,559
  8,995
EBITDA, $m
  1,698
  2,092
  2,234
  2,382
  2,536
  2,696
  2,863
  3,037
  3,217
  3,406
  3,603
  3,808
  4,022
  4,246
  4,480
  4,725
  4,980
  5,248
  5,528
  5,821
  6,127
  6,449
  6,785
  7,138
  7,507
  7,895
  8,301
  8,726
  9,173
  9,641
  10,132
Interest expense (income), $m
  107
  144
  157
  172
  187
  203
  220
  237
  255
  273
  293
  313
  334
  356
  379
  403
  428
  455
  482
  511
  541
  573
  606
  640
  676
  714
  754
  796
  840
  886
  934
Earnings before tax, $m
  1,156
  1,335
  1,448
  1,564
  1,686
  1,812
  1,944
  2,081
  2,223
  2,372
  2,527
  3,068
  3,237
  3,414
  3,598
  3,791
  3,993
  4,204
  4,425
  4,656
  4,899
  5,152
  5,418
  5,696
  5,988
  6,294
  6,615
  6,951
  7,303
  7,673
  8,061
Tax expense, $m
  409
  361
  391
  422
  455
  489
  525
  562
  600
  640
  682
  828
  874
  922
  972
  1,024
  1,078
  1,135
  1,195
  1,257
  1,323
  1,391
  1,463
  1,538
  1,617
  1,699
  1,786
  1,877
  1,972
  2,072
  2,176
Net income, $m
  702
  975
  1,057
  1,142
  1,231
  1,323
  1,419
  1,519
  1,623
  1,732
  1,845
  2,239
  2,363
  2,492
  2,627
  2,768
  2,915
  3,069
  3,230
  3,399
  3,576
  3,761
  3,955
  4,158
  4,371
  4,595
  4,829
  5,074
  5,332
  5,601
  5,885

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  34
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  10,318
  11,000
  11,748
  12,525
  13,334
  14,176
  15,052
  15,965
  16,916
  17,907
  18,941
  20,020
  21,147
  22,324
  23,553
  24,839
  26,183
  27,589
  29,061
  30,601
  32,214
  33,903
  35,672
  37,526
  39,469
  41,505
  43,640
  45,878
  48,226
  50,687
  53,269
Adjusted assets (=assets-cash), $m
  10,284
  11,000
  11,748
  12,525
  13,334
  14,176
  15,052
  15,965
  16,916
  17,907
  18,941
  20,020
  21,147
  22,324
  23,553
  24,839
  26,183
  27,589
  29,061
  30,601
  32,214
  33,903
  35,672
  37,526
  39,469
  41,505
  43,640
  45,878
  48,226
  50,687
  53,269
Revenue / Adjusted assets
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
  0.950
Average production assets, $m
  4,084
  4,368
  4,665
  4,974
  5,295
  5,629
  5,977
  6,340
  6,717
  7,111
  7,521
  7,950
  8,397
  8,865
  9,353
  9,863
  10,397
  10,956
  11,540
  12,152
  12,792
  13,463
  14,165
  14,902
  15,673
  16,482
  17,329
  18,218
  19,150
  20,128
  21,153
Working capital, $m
  364
  470
  502
  535
  570
  606
  643
  682
  723
  766
  810
  856
  904
  954
  1,007
  1,062
  1,119
  1,179
  1,242
  1,308
  1,377
  1,449
  1,525
  1,604
  1,687
  1,774
  1,866
  1,961
  2,062
  2,167
  2,277
Total debt, $m
  4,136
  4,500
  4,918
  5,353
  5,805
  6,275
  6,765
  7,275
  7,807
  8,361
  8,939
  9,542
  10,172
  10,830
  11,517
  12,236
  12,987
  13,773
  14,596
  15,457
  16,358
  17,303
  18,292
  19,328
  20,414
  21,552
  22,746
  23,997
  25,309
  26,685
  28,129
Total liabilities, $m
  5,785
  6,149
  6,567
  7,002
  7,454
  7,924
  8,414
  8,924
  9,456
  10,010
  10,588
  11,191
  11,821
  12,479
  13,166
  13,885
  14,636
  15,422
  16,245
  17,106
  18,007
  18,952
  19,941
  20,977
  22,063
  23,201
  24,395
  25,646
  26,958
  28,334
  29,778
Total equity, $m
  4,533
  4,851
  5,181
  5,524
  5,880
  6,252
  6,638
  7,040
  7,460
  7,897
  8,353
  8,829
  9,326
  9,845
  10,387
  10,954
  11,547
  12,167
  12,816
  13,495
  14,206
  14,951
  15,731
  16,549
  17,406
  18,304
  19,245
  20,232
  21,267
  22,353
  23,492
Total liabilities and equity, $m
  10,318
  11,000
  11,748
  12,526
  13,334
  14,176
  15,052
  15,964
  16,916
  17,907
  18,941
  20,020
  21,147
  22,324
  23,553
  24,839
  26,183
  27,589
  29,061
  30,601
  32,213
  33,903
  35,672
  37,526
  39,469
  41,505
  43,640
  45,878
  48,225
  50,687
  53,270
Debt-to-equity ratio
  0.912
  0.930
  0.950
  0.970
  0.990
  1.000
  1.020
  1.030
  1.050
  1.060
  1.070
  1.080
  1.090
  1.100
  1.110
  1.120
  1.120
  1.130
  1.140
  1.150
  1.150
  1.160
  1.160
  1.170
  1.170
  1.180
  1.180
  1.190
  1.190
  1.190
  1.200
Adjusted equity ratio
  0.437
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441
  0.441

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  702
  975
  1,057
  1,142
  1,231
  1,323
  1,419
  1,519
  1,623
  1,732
  1,845
  2,239
  2,363
  2,492
  2,627
  2,768
  2,915
  3,069
  3,230
  3,399
  3,576
  3,761
  3,955
  4,158
  4,371
  4,595
  4,829
  5,074
  5,332
  5,601
  5,885
Depreciation, amort., depletion, $m
  417
  613
  629
  646
  663
  681
  700
  719
  740
  761
  783
  427
  451
  477
  503
  530
  559
  589
  620
  653
  688
  724
  762
  801
  843
  886
  932
  979
  1,030
  1,082
  1,137
Funds from operations, $m
  1,365
  1,588
  1,686
  1,788
  1,894
  2,004
  2,119
  2,238
  2,363
  2,492
  2,628
  2,667
  2,814
  2,968
  3,130
  3,298
  3,474
  3,658
  3,851
  4,052
  4,264
  4,485
  4,717
  4,960
  5,214
  5,481
  5,760
  6,054
  6,361
  6,684
  7,022
Change in working capital, $m
  77
  31
  32
  33
  35
  36
  37
  39
  41
  42
  44
  46
  48
  50
  53
  55
  57
  60
  63
  66
  69
  72
  76
  79
  83
  87
  91
  96
  100
  105
  110
Cash from operations, $m
  1,288
  1,805
  1,654
  1,755
  1,859
  1,968
  2,081
  2,199
  2,322
  2,450
  2,584
  2,621
  2,766
  2,918
  3,077
  3,243
  3,416
  3,598
  3,788
  3,987
  4,195
  4,413
  4,641
  4,880
  5,131
  5,394
  5,669
  5,958
  6,261
  6,578
  6,911
Maintenance CAPEX, $m
  0
  -220
  -235
  -251
  -267
  -285
  -303
  -321
  -341
  -361
  -382
  -404
  -427
  -451
  -477
  -503
  -530
  -559
  -589
  -620
  -653
  -688
  -724
  -762
  -801
  -843
  -886
  -932
  -979
  -1,030
  -1,082
New CAPEX, $m
  -541
  -284
  -297
  -309
  -321
  -334
  -348
  -362
  -378
  -394
  -411
  -429
  -447
  -467
  -488
  -510
  -534
  -558
  -584
  -612
  -640
  -671
  -703
  -736
  -771
  -809
  -848
  -889
  -932
  -978
  -1,025
Cash from investing activities, $m
  -1,187
  -504
  -532
  -560
  -588
  -619
  -651
  -683
  -719
  -755
  -793
  -833
  -874
  -918
  -965
  -1,013
  -1,064
  -1,117
  -1,173
  -1,232
  -1,293
  -1,359
  -1,427
  -1,498
  -1,572
  -1,652
  -1,734
  -1,821
  -1,911
  -2,008
  -2,107
Free cash flow, $m
  101
  1,301
  1,122
  1,195
  1,271
  1,349
  1,431
  1,515
  1,603
  1,695
  1,791
  1,788
  1,891
  1,999
  2,112
  2,230
  2,352
  2,481
  2,615
  2,755
  2,901
  3,054
  3,215
  3,383
  3,558
  3,742
  3,935
  4,137
  4,349
  4,571
  4,804
Issuance/(repayment) of debt, $m
  712
  398
  418
  435
  452
  470
  490
  510
  532
  554
  578
  603
  630
  658
  687
  719
  751
  786
  823
  861
  902
  944
  989
  1,036
  1,086
  1,138
  1,193
  1,251
  1,312
  1,376
  1,443
Issuance/(repurchase) of shares, $m
  -344
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  -87
  398
  418
  435
  452
  470
  490
  510
  532
  554
  578
  603
  630
  658
  687
  719
  751
  786
  823
  861
  902
  944
  989
  1,036
  1,086
  1,138
  1,193
  1,251
  1,312
  1,376
  1,443
Total cash flow (excl. dividends), $m
  12
  1,699
  1,540
  1,630
  1,723
  1,820
  1,920
  2,025
  2,135
  2,249
  2,369
  2,391
  2,521
  2,657
  2,799
  2,948
  3,104
  3,267
  3,437
  3,616
  3,803
  3,998
  4,204
  4,419
  4,644
  4,881
  5,129
  5,389
  5,661
  5,947
  6,247
Retained Cash Flow (-), $m
  -283
  -318
  -330
  -343
  -357
  -371
  -386
  -402
  -419
  -437
  -456
  -476
  -497
  -519
  -542
  -567
  -593
  -620
  -649
  -679
  -711
  -745
  -780
  -818
  -857
  -898
  -941
  -987
  -1,035
  -1,086
  -1,139
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  1,381
  1,211
  1,287
  1,366
  1,448
  1,534
  1,623
  1,716
  1,812
  1,913
  1,915
  2,024
  2,138
  2,257
  2,381
  2,511
  2,646
  2,788
  2,936
  3,091
  3,254
  3,423
  3,601
  3,788
  3,983
  4,187
  4,402
  4,626
  4,862
  5,109
Discount rate, %
 
  7.00
  7.35
  7.72
  8.10
  8.51
  8.93
  9.38
  9.85
  10.34
  10.86
  11.40
  11.97
  12.57
  13.20
  13.86
  14.55
  15.28
  16.04
  16.85
  17.69
  18.57
  19.50
  20.48
  21.50
  22.58
  23.70
  24.89
  26.13
  27.44
  28.81
PV of cash for distribution, $m
 
  1,290
  1,050
  1,030
  1,000
  963
  918
  866
  809
  747
  682
  584
  521
  459
  398
  340
  286
  236
  191
  152
  119
  91
  68
  50
  35
  25
  17
  11
  7
  4
  3
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The company’s hospitals provide various services, including general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 25, 2016, it owned and/or operated 24 inpatient acute care hospitals, 3 free-standing emergency departments, and 213 inpatient and 16 outpatient behavioral health care facilities located in 37 states, Washington, D.C.; the United Kingdom; Puerto Rico; and the U.S. Virgin Islands. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

FINANCIAL RATIOS  of  Universal Health Services Cl B (UHS)

Valuation Ratios
P/E Ratio 16.4
Price to Sales 1.2
Price to Book 2.5
Price to Tangible Book
Price to Cash Flow 8.9
Price to Free Cash Flow 15.4
Growth Rates
Sales Growth Rate 8%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 42.7%
Cap. Spend. - 3 Yr. Gr. Rate 5.8%
Financial Strength
Quick Ratio 0
Current Ratio 0.1
LT Debt to Equity 88.9%
Total Debt to Equity 91.2%
Interest Coverage 12
Management Effectiveness
Return On Assets 7.7%
Ret/ On Assets - 3 Yr. Avg. 7.7%
Return On Total Capital 8.6%
Ret/ On T. Cap. - 3 Yr. Avg. 8.6%
Return On Equity 16%
Return On Equity - 3 Yr. Avg. 16.2%
Asset Turnover 1
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 17.2%
EBITDA Margin - 3 Yr. Avg. 17.7%
Operating Margin 13.1%
Oper. Margin - 3 Yr. Avg. 13.3%
Pre-Tax Margin 11.8%
Pre-Tax Margin - 3 Yr. Avg. 11.9%
Net Profit Margin 7.2%
Net Profit Margin - 3 Yr. Avg. 7.1%
Effective Tax Rate 35.4%
Eff/ Tax Rate - 3 Yr. Avg. 34.9%
Payout Ratio 5.6%

UHS stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the UHS stock intrinsic value calculation we used $9766 million for the last fiscal year's total revenue generated by Universal Health Services Cl B. The default revenue input number comes from 2016 income statement of Universal Health Services Cl B. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our UHS stock valuation model: a) initial revenue growth rate of 7% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7%, whose default value for UHS is calculated based on our internal credit rating of Universal Health Services Cl B, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Universal Health Services Cl B.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of UHS stock the variable cost ratio is equal to 86.1%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for UHS stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Universal Health Services Cl B.

Corporate tax rate of 27% is the nominal tax rate for Universal Health Services Cl B. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the UHS stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for UHS are equal to 41.8%.

Life of production assets of 18.6 years is the average useful life of capital assets used in Universal Health Services Cl B operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for UHS is equal to 4.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $4533 million for Universal Health Services Cl B - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 95.701 million for Universal Health Services Cl B is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Universal Health Services Cl B at the current share price and the inputted number of shares is $11.4 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
CYH Community Heal 8.24 25.87  str.buy
THC Tenet Healthca 15.35 33.42  str.buy
HCA HCA Holdings 83.55 43.21  str.sell
ACHC Acadia Healthc 43.08 149.55  str.buy
QHC Quorum Health 4.49 1.03  str.sell
ADPT Adeptus Health 1.41 14.80  str.buy

COMPANY NEWS

▶ 10 Most Profitable For Profit Hospitals in America   [Mar-31-17 05:05PM  at Insider Monkey]
▶ Universal Health Services CEO on GOP's Health Care Loss   [Mar-30-17 07:18PM  Bloomberg Video]
Stock chart of UHS Financial statements of UHS
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.